Mark Mannebach
Consejero General en HARROW, INC. .
Perfil
Mark Mannebach is currently the Head of Regulatory Affairs & Pharmacovigilance at Harrow, Inc. and the Vice President of Regulatory Affairs at Celcuity, Inc. He previously held positions as the Vice President of Global Regulatory Affairs at Eiger BioPharmaceuticals, Inc., Exicure, Inc., Santen, Inc., and Mallinckrodt Pharmaceuticals.
Dr. Mannebach has a background in regulatory affairs and pharmacovigilance.
He obtained his undergraduate degree from Wayne State University, his graduate degree from the University of Detroit Mercy, and his doctorate from the University of Michigan.
Cargos activos de Mark Mannebach
Empresas | Cargo | Inicio |
---|---|---|
HARROW, INC. | Consejero General | 06/03/2023 |
CELCUITY INC. | Consejero General | 01/04/2022 |
Antiguos cargos conocidos de Mark Mannebach.
Empresas | Cargo | Fin |
---|---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Consejero General | 01/11/2008 |
EXICURE, INC. | Consejero General | - |
EIGER BIOPHARMACEUTICALS, INC. | Consejero General | - |
Formación de Mark Mannebach.
University of Michigan | Doctorate Degree |
University of Detroit Mercy | Graduate Degree |
Wayne State University (Michigan) | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
EXICURE, INC. | Health Technology |
HARROW, INC. | Health Technology |
CELCUITY INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Mannebach